GWS
ADPT icon

Glassman Wealth Services’s Adaptive Biotechnologies ADPT Stock Holding History

Glassman Wealth Services’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48
Closed -$322 – 1990
2023
Q2 		$322 Hold
48
– – ﹤0.01% 1724
2023
Q1 		$424 Hold
48
– – ﹤0.01% 1643
2022
Q4 		$367 Sell
48
-135
-74% -$1.05K ﹤0.01% 1683
2022
Q3 		$1K Sell
183
-6
-3% -$57 ﹤0.01% 1308
2022
Q2 		$2K Sell
189
-355
-65% -$3.12K ﹤0.01% 1190
2022
Q1 		$8K Buy
544
+233
+75% +$3.66K ﹤0.01% 878
2021
Q4 		$9K Buy
311
+134
+76% +$4.11K ﹤0.01% 809
2021
Q3 		$6K Buy
+177
New +$6.4K ﹤0.01% 890
2021
Q2 		– Sell
-94
Closed -$4K – 1431
2021
Q1 		$4K Sell
94
-1
-1% -$54 ﹤0.01% 899
2020
Q4 		$6K Buy
95
+14
+17% +$722 ﹤0.01% 815
2020
Q3 		$4K Buy
81
+52
+179% +$2.19K ﹤0.01% 818
2020
Q2 		$1K Buy
+29
New +$1.06K ﹤0.01% 944

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Glassman Wealth Services's ADPT Position: Q3 2023 in Review

Glassman Wealth Services sold out of Adaptive Biotechnologies (ADPT) in Q3 2023, closing a stake of 48 shares — an estimated $322 sold.

Glassman Wealth Services first reported a position in ADPT in Q2 2020 and held it in 12 quarters. The position peaked at $9K in Q4 2021. 190 funds tracked by Wall St. Rank hold ADPT as of Q3 2023.

  • Glassman Wealth Services reported no remaining Adaptive Biotechnologies position as of Q3 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 48 Adaptive Biotechnologies shares in Q3 2023, an estimated $322.
  • Glassman Wealth Services first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 12 quarters.
  • Glassman Wealth Services's Adaptive Biotechnologies position peaked at $9K in Q4 2021.
  • 190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2023.

Based on Glassman Wealth Services's 13F filing for Q3 2023, filed 14 Nov 2023.